Company profile: Pairwise
1.1 - Company Overview
Company description
- Provider of plant-based innovation via the Fulcrum platform to accelerate production systems, developing seedless blackberries, black raspberries, red raspberries, and pitless cherries with year-round availability, and offering the Good Food for All program to expand access to fruits and vegetables.
Products and services
- Seedless and pitless fruits: Pairwise architects custom-developed varieties—seedless blackberries, black raspberries, red raspberries, and pitless cherries—created for year-round availability to deliver consistent supply
- Fulcrum™ platform: A modular platform engineered to accelerate innovation in plant-based production systems, enabling faster iteration and advancement in plant-based production workflows
- Good Food for All program: A community-scale initiative that makes fruits and vegetables more accessible, aiming to deliver 210,000 servings each year to broaden availability
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Pairwise
Organ-i
HQ: United States
Website
- Description: Provider of novel biotech diagnostic tests for renal diseases, improving clinicians’ ability to monitor the health of transplanted kidneys and providing valuable treatment information for patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Organ-i company profile →
Lentigen Technology
HQ: United States
Website
- Description: Provider of gene delivery technologies and CDMO services for cell and gene therapy products, offering lentiviral vector technology for therapeutic, vaccine, and research applications; lentiviral vector design, evaluation, and scalable manufacturing; process development and clinical manufacturing; assay development via automated flow cytometry; and regulatory support from pre-IND to approval.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lentigen Technology company profile →
Identigen
HQ: Ireland
Website
- Description: Provider of DNA-based solutions to the agri-food industry, applying genetic identification to improve the quality, integrity and safety of the global food supply. Offers DNA TRACEBACK for verifying food origin and production practices, and DATALIVE for animal lifecycle insights to support sustainable business and environmental practices. Operates in Ireland, UK, EU, USA and Canada.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Identigen company profile →
Guide Therapeutics
HQ: United States
Website
- Description: Provider of biotechnology solutions addressing delivery of genetic therapies, leveraging patented technologies to test thousands of chemically distinct nanoparticles in vivo to identify simple, scalable, clinically relevant nanoparticles that target new cell types efficiently and safely.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Guide Therapeutics company profile →
QuantRx Biomedical
HQ: United States
Website
- Description: Provider of diagnostic products for the healthcare industry, focusing on their development and commercialization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full QuantRx Biomedical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Pairwise
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Pairwise
2.2 - Growth funds investing in similar companies to Pairwise
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Pairwise
4.2 - Public trading comparable groups for Pairwise
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →